These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.
Lilly last week reported a rare $1.5 billion sales miss for its injectable obesity drug Zepbound and diabetes medicine Mounjaro combined, raising concerns among investors that demand might be cooling ...
The Danish drugmaker plans to introduce a combination drug, CagriSema, that could result in 25% weight loss — higher than ...
During a routine wellness check, the doctor’s words struck a chord with Maria Parsell: her blood sugar had climbed to a pre-diabetic range.
BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of ...
Oatmeal can be a good option for people with diabetes because it is rich in fiber, a key nutrient in blood sugar control.
Novo Nordisk's (NVO) semaglutide, marketed as Wegovy for obesity, shows promise in reducing joint disease symptoms in ...